Malaga Cove Capital’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-3,950
Closed -$1.27M 169
2021
Q1
$1.27M Sell
3,950
-77
-2% -$24.6K 0.54% 64
2020
Q4
$1.32M Sell
4,027
-244
-6% -$67.5K 0.62% 60
2020
Q3
$1.18M Buy
4,271
+40
+0.9% +$11.5K 0.69% 51
2020
Q2
$1.02M Sell
4,231
-74
-2% -$14.9K 0.62% 62
2020
Q1
$626K Sell
4,305
-131
-3% -$21.7K 0.51% 77
2019
Q4
$757K Sell
4,436
-129
-3% -$23.9K 0.47% 84
2019
Q3
$812K Buy
4,565
+1,500
+49% +$324K 0.55% 70
2019
Q2
$798K Buy
+3,065
New +$813K 0.51% 73

Other funds holding ABMD

Malaga Cove Capital's ABMD Position: Q2 2021 in Review

Malaga Cove Capital sold out of Abiomed Inc (ABMD) in Q2 2021, closing a stake of 3,950 shares — an estimated $1.27M sold.

Malaga Cove Capital first reported a position in ABMD in Q2 2019 and held it in 8 quarters. The position peaked at $1.32M in Q4 2020. 474 funds tracked by Wall St. Rank hold ABMD as of Q2 2021.

  • Malaga Cove Capital reported no remaining Abiomed Inc position as of Q2 2021 after selling out during the quarter.
  • Malaga Cove Capital sold 3,950 Abiomed Inc shares in Q2 2021, an estimated $1.27M.
  • Malaga Cove Capital first reported a position in Abiomed Inc in Q2 2019 and held it in 8 quarters.
  • Malaga Cove Capital's Abiomed Inc position peaked at $1.32M in Q4 2020.
  • 474 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2021.

Based on Malaga Cove Capital's 13F filing for Q2 2021, filed 27 Jul 2021.